341 related articles for article (PubMed ID: 25277614)
1. Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress.
Nigam A; Talajic M; Roy D; Nattel S; Lambert J; Nozza A; Jones P; Ramprasath VR; O'Hara G; Kopecky S; Brophy JM; Tardif JC;
J Am Coll Cardiol; 2014 Oct; 64(14):1441-8. PubMed ID: 25277614
[TBL] [Abstract][Full Text] [Related]
2. Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion.
Kumar S; Sutherland F; Morton JB; Lee G; Morgan J; Wong J; Eccleston DE; Voukelatos J; Garg ML; Sparks PB
Heart Rhythm; 2012 Apr; 9(4):483-91. PubMed ID: 22120130
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial.
Kowey PR; Reiffel JA; Ellenbogen KA; Naccarelli GV; Pratt CM
JAMA; 2010 Dec; 304(21):2363-72. PubMed ID: 21078810
[TBL] [Abstract][Full Text] [Related]
4. n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study.
Bianconi L; Calò L; Mennuni M; Santini L; Morosetti P; Azzolini P; Barbato G; Biscione F; Romano P; Santini M
Europace; 2011 Feb; 13(2):174-81. PubMed ID: 21059740
[TBL] [Abstract][Full Text] [Related]
5. Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.
Mozaffarian D; Marchioli R; Macchia A; Silletta MG; Ferrazzi P; Gardner TJ; Latini R; Libby P; Lombardi F; O'Gara PT; Page RL; Tavazzi L; Tognoni G;
JAMA; 2012 Nov; 308(19):2001-11. PubMed ID: 23128104
[TBL] [Abstract][Full Text] [Related]
6. Effect of dietary fish oil on atrial fibrillation after cardiac surgery.
Farquharson AL; Metcalf RG; Sanders P; Stuklis R; Edwards JR; Gibson RA; Cleland LG; Sullivan TR; James MJ; Young GD
Am J Cardiol; 2011 Sep; 108(6):851-6. PubMed ID: 21762871
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.
Macchia A; Grancelli H; Varini S; Nul D; Laffaye N; Mariani J; Ferrante D; Badra R; Figal J; Ramos S; Tognoni G; Doval HC;
J Am Coll Cardiol; 2013 Jan; 61(4):463-468. PubMed ID: 23265344
[TBL] [Abstract][Full Text] [Related]
8. N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study.
Ozaydın M; Erdoğan D; Tayyar S; Uysal BA; Doğan A; Içli A; Ozkan E; Varol E; Türker Y; Arslan A
Anadolu Kardiyol Derg; 2011 Jun; 11(4):305-9. PubMed ID: 21543294
[TBL] [Abstract][Full Text] [Related]
9. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation.
Hatzinikolaou-Kotsakou E; Tziakas D; Hotidis A; Stakos D; Floros D; Papanas N; Chalikias G; Maltezos E; Hatseras DI
Am J Cardiol; 2006 Mar; 97(5):659-61. PubMed ID: 16490433
[TBL] [Abstract][Full Text] [Related]
10. Effect of omega-three polyunsaturated fatty acids on inflammation, oxidative stress, and recurrence of atrial fibrillation.
Vanderbilt C; Free M; Li J; Gebretsadik T; Bian A; Shintani A; McBride BF; Solus J; Milne G; Crossley GH; Thompson D; Vidaillet H; Okafor H; Darbar D; Murray KT; Stein CM
Am J Cardiol; 2015 Jan; 115(2):196-201. PubMed ID: 25465932
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement.
Rodrigo R; Korantzopoulos P; Cereceda M; Asenjo R; Zamorano J; Villalabeitia E; Baeza C; Aguayo R; Castillo R; Carrasco R; Gormaz JG
J Am Coll Cardiol; 2013 Oct; 62(16):1457-65. PubMed ID: 23916928
[TBL] [Abstract][Full Text] [Related]
12. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human pulmonary vein and left atrial electrophysiology in paroxysmal atrial fibrillation.
Kumar S; Sutherland F; Teh AW; Heck PM; Lee G; Garg ML; Sparks PB
Am J Cardiol; 2011 Aug; 108(4):531-5. PubMed ID: 21624541
[TBL] [Abstract][Full Text] [Related]
14. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study.
Deftereos S; Giannopoulos G; Kossyvakis C; Efremidis M; Panagopoulou V; Kaoukis A; Raisakis K; Bouras G; Angelidis C; Theodorakis A; Driva M; Doudoumis K; Pyrgakis V; Stefanadis C
J Am Coll Cardiol; 2012 Oct; 60(18):1790-6. PubMed ID: 23040570
[TBL] [Abstract][Full Text] [Related]
15. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy.
Demir K; Can I; Koc F; Vatankulu MA; Ayhan S; Akilli H; Aribas A; Alihanoglu Y; Altunkeser BB
Med Princ Pract; 2011; 20(5):464-9. PubMed ID: 21757938
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term ω-3 polyunsaturated fatty acid supplementation on paroxysmal atrial tachyarrhythmia burden in patients with implanted pacemakers: results from a prospective randomised study.
Kumar S; Sutherland F; Stevenson I; Lee JM; Garg ML; Sparks PB
Int J Cardiol; 2013 Oct; 168(4):3812-7. PubMed ID: 23890856
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study.
Pratt CM; Reiffel JA; Ellenbogen KA; Naccarelli GV; Kowey PR
Am Heart J; 2009 Aug; 158(2):163-169.e1-3. PubMed ID: 19619690
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study.
Heidt MC; Vician M; Stracke SK; Stadlbauer T; Grebe MT; Boening A; Vogt PR; Erdogan A
Thorac Cardiovasc Surg; 2009 Aug; 57(5):276-80. PubMed ID: 19629889
[TBL] [Abstract][Full Text] [Related]
20. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
